We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 2,961 results
  1. Surgical implantation of human adipose derived stem cells attenuates experimentally induced hepatic fibrosis in rats

    Background

    Mesenchymal stem cells (MSCs) are multipotent stromal cells and could exert hepatoprotective effects against acute liver injury,...

    Masateru Nomura, Joseph George, ... Mikihiro Tsutsumi in Molecular Medicine
    Article Open access 29 November 2022
  2. Proteomic profiling of murine biliary-derived hepatic organoids and their capacity for drug disposition, bioactivation and detoxification

    Hepatic organoids are a recent innovation in in vitro modeling. Initial studies suggest that organoids better recapitulate the liver phenotype in...

    Lawrence Howell, Rosalind E. Jenkins, ... Christopher Goldring in Archives of Toxicology
    Article Open access 29 May 2021
  3. Molecular Pathways and Animal Models of Defects in Situs

    Left–right patterning is among the least well understood of the three axes defining the body plan, and yet it is no less important, with left–right...
    George C. Gabriel, Cecilia W. Lo in Congenital Heart Diseases: The Broken Heart
    Chapter 2024
  4. Bipotent transitional liver progenitor cells contribute to liver regeneration

    Following severe liver injury, when hepatocyte-mediated regeneration is impaired, biliary epithelial cells (BECs) can transdifferentiate into...

    Wenjuan Pu, Huan Zhu, ... Bin Zhou in Nature Genetics
    Article Open access 13 March 2023
  5. Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers

    Liver cancer is one of the most prevalent cancers, and the third most common cause of cancer-related mortality worldwide. The therapeutic options for...

    Guoying Zhou, Patrick P. C. Boor, ... Jaap Kwekkeboom in British Journal of Cancer
    Article 16 August 2021
  6. Genetic association and causal relationship between multiple modifiable risk factors and autoimmune liver disease: a two-sample mendelian randomization study

    Background

    The intricate etiology of autoimmune liver disease (AILD) involves genetic, environmental, and other factors that yet to be completely...

    Weize Gao, Chong Peng, ... Mingjun Liu in Journal of Translational Medicine
    Article Open access 04 May 2024
  7. Hepatocellular Carcinoma and Human Gut Microbiome: Association with Disease and Scope for Therapeutic Intervention

    Hepatocellular carcinoma (HCC) is the world’s third most prevalent cause of cancer-related mortality. HCC frequently occurs in patients with chronic...
    Ishfaq Hassan Mir, Saqib Hassan, ... Chinnasamy Thirunavukkarasu in Human Microbiome in Health, Disease, and Therapy
    Chapter 2023
  8. Coffee, adenosine, and the liver

    A variety of observational studies have demonstrated that coffee, likely acting through caffeine, improves health outcomes in patients with chronic...

    Jonathan A. Dranoff in Purinergic Signalling
    Article 27 September 2023
  9. Safety profile of autologous macrophage therapy for liver cirrhosis

    Therapies to reduce liver fibrosis and stimulate organ regeneration are urgently needed. We conducted a first-in-human, phase 1 dose-escalation trial...

    Francesca Moroni, Benjamin J. Dwyer, ... Stuart J. Forbes in Nature Medicine
    Article 07 October 2019
  10. Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma

    Objective

    Gut mycobiota plays a crucial role in benign liver diseases; however, its correlation with hepatocellular carcinoma (HCC) remains elusive....

    Lilong Zhang, Chen Chen, ... Weixing Wang in Journal of Translational Medicine
    Article Open access 15 February 2023
  11. Clinical and imaging characteristics of primary hepatic sarcomatoid carcinoma and sarcoma: a comparative study

    Background

    Primary hepatic sarcomatous carcinoma (PHSC) and primary hepatic sarcoma (PHS) are rare malignancies with frequent overlap in both the...

    Dongli Shi, Jun Sun, ... Hongjun Li in BMC Cancer
    Article Open access 09 October 2020
  12. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation

    Background

    Progressive familial intrahepatic cholestasis (PFIC) type 3 is an autosomal recessive disorder arising from mutations in the ATP-binding...

    Mariam Goubran, Ayodeji Aderibigbe, ... Andrew L. Mason in BMC Medical Genetics
    Article Open access 30 November 2020
  13. Copper

    Reference work entry 2024
  14. Modified staging system of positive lymph nodes based nomogram in intrahepatic cholangiocarcinoma

    Background

    Intrahepatic cholangiocarcinoma (iCCA) presents the similar trend and prevalence of lymph node metastasis to other biliary tract cancer....

    Chongyu Zhao, **yuan Li, ... Chaobin He in Cancer Cell International
    Article Open access 29 July 2023
  15. Risk factors for antibiotic resistance and mortality in patients with bloodstream infection of Escherichia coli

    This study aimed to investigate the risk factors for bloodstream infection (BSI) caused by extended-spectrum beta-lactamase (ESBL)–producing Escherichi...

    Shun** Zhao, Ying**g Wu, ... Jun Zhao in European Journal of Clinical Microbiology & Infectious Diseases
    Article 21 February 2022
  16. Liver Cancer

    Liver cancer is a major lethal malignancy worldwide. This chapter describes the molecular pathogenesis of the main histological subtype,...
    Wolfgang A. Schulz in Molecular Biology of Human Cancers
    Chapter 2023
  17. Biallelic mutations of TTC12 and TTC21B were identified in Chinese patients with multisystem ciliopathy syndromes

    Background

    Abnormalities in cilia ultrastructure and function lead to a range of human phenotypes termed ciliopathies. Many tetratricopeptide repeat...

    Weicheng Chen, Feifei Wang, ... **angyu Zhou in Human Genomics
    Article Open access 22 October 2022
  18. How genetic risk contributes to autoimmune liver disease

    Genome-wide association studies (GWAS) for autoimmune hepatitis (AIH) and GWAS/genome-wide meta-analyses (GWMA) for primary biliary cholangitis (PBC)...

    David Ellinghaus in Seminars in Immunopathology
    Article Open access 01 June 2022
  19. The gut-liver axis in hepatobiliary diseases

    Recent advances in the analysis of intestinal bacteria have led to reports of variations in intestinal bacterial levels among hepatobiliary diseases....

    Masataka Ichikawa, Haruka Okada, ... Takanori Kanai in Inflammation and Regeneration
    Article Open access 08 January 2024
  20. The crosstalk between cholangiocytes and hepatic stellate cells promotes the progression of epithelial-mesenchymal transition and periductal fibrosis during Clonorchis sinensis infection

    Background

    Clonorchis sinensis infection is one of the risk factors that provokes chronic inflammation, epithelial hyperplasia, periductal fibrosis...

    Junyeong Yi, Ji Hoon Jeong, ... Jhang Ho Pak in Parasites & Vectors
    Article Open access 22 March 2024
Did you find what you were looking for? Share feedback.